| Cata #: | Name of Product: | Price: |
| HRP-4392 | Recombinant YFP-Human DNPH1 Protein | $300 |

| Product Name: | Recombinant YFP-Human DNPH1 Protein |
| Catalog #: | HRP-4392 |
| Manufacture: | LD Biopharma, Inc. |
| Introduction: | Human 5-hydroxymethyl-dUMP N-hydrolase (DNPH1) encodes a enzyme, which is part of a nucleotide salvage pathway that eliminates epigenetically modified 5-hydroxymethyl-dCMP (hmdCMP) in a two-step process entailing deamination to cytotoxic 5-hydroxymethyl-dUMP (hmdUMP), followed by its hydrolysis into 5-hydroxymethyluracil (hmU) and 2-deoxy-D-ribose 5-phosphate (deoxyribosephosphate). It catalyzes the second step in that pathway, the hydrolysis of the N-glycosidic bond in hmdUMP, degrading this cytotoxic nucleotide to avoid its genomic integration. Recent data indicated that genomic hmdU is a key determinant of PARP inhibitor sensitivity, targeting DNPH1 may provide a promising strategy for the hypersensitization of BRCA-deficient cancers to PARP inhibitor therapy.
|
| Gene Symbol: | DNPH1 ( C6orf108; RCL ) |
| Accession Number: | NP_006434 |
| Species: | Human |
| Package Size: | 50µg / Vial |
| Composition: | 1.0 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, Sucrose, DTT and others. |
| Storage: | In Liquid. Keep at -80°C for long term storage. Product is stable at 4 °C for at least two weeks. |
| Key Reference: | Kasper Fugger, et al.,Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors. Science, vol 372. Issue 6538. pp:156 – 165. (2021). DOI: 10.1126/science.abb4542 |
| Applications: |
|
| Quality Control: | Purity: > 92 % by SDS-PAGE. |
| Recombinant Protein Sequence: | MKHHHHHHQVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLLCTTGKLPVPWPTLVTTLGYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSYQSALFKDPNEKRDHMVLLEFLTAAGITEGMNELYKGSENLYFQGEFAAAMVPGRSESWERGEPGRPALYFCGSIRGGREDRTLYERIVSRLRRFGTVLTEHVAAAELGARGEEAAGGDRLIHEQDLEWLQQADVVVAEVTQPSLGVGYELGRAVAFNKRILCLFRPQSGRVLSAMIRGAADGSRFQVWDYEEGEVEALLDRYFEADPPGQVAASPDPTT |